retatrutide type 2 diabetes trial results 2024 Effects of retatrutide, dulaglutide, and placebo on gastric emptying in Lilly's triple agonist achieves 16.8%

This medications impact is especially significant for individuals struggling with obesity or those looking for an effective and sustainable approach to managing their weight

Maintaining a stable weight matters because removed fat cells do not return, while remaining fat cells can expand with weight gain

Nausea: the most common early experience Nausea is the most frequently reported side effect with retatrutide, occurring in 14% of participants at 1mg up to 60% at 12mg in clinical trials

Differences Between Semaglutide vs

This article is exclusive to STAT+ subscribers Unlock this article plus daily coverage and analysis of the pharma industry by subscribing to STAT+

The combination of significant weight loss potential, appetite control, and metabolic improvements makes Retatrutide benefits compelling for many individuals